The VP of Access Strategy & Payer Engagement will define and execute the company's market access, pricing, and HEOR strategies to ensure optimal product coverage and reimbursement. This role involves leading senior-level negotiations with national payers and PBMs while partnering cross-functionally to integrate access strategy into brand planning and financial decision-making.
The Corporate Account Director will develop and execute account strategies for Retina Consultants of America to ensure product access and growth. They will manage senior-level relationships, oversee contract negotiations, and collaborate cross-functionally to drive financial and operational outcomes.
The ED/VP will design and execute national patient access and reimbursement strategies while leading field-based teams to remove barriers for specialty pharmaceutical products. This role involves cross-functional collaboration to ensure launch-ready infrastructure and effective provider support programs.
The ED/VP will lead the GPO and corporate account strategy, focusing on building relationships with key stakeholders in the Retina space and managing the DEXTENZA account team. This role involves overseeing contract negotiations, driving performance management, and developing a high-performing field-based team.
Lead strategic relationships and integrated account plans with priority payers, health systems, IDNs, academic institutions, and other national healthcare organizations, translating clinical and economic evidence into meaningful value discussions. Build and develop a national account team and operating model, identify evidence and collaboration opportunities, communicate external insights to leadership, and ensure compliant account engagement.
The Corporate Account Director will develop and execute strategic account plans to drive growth for DEXTENZA within designated corporate accounts. This role involves negotiating contracts, managing relationships with C-suite stakeholders, and collaborating with internal teams to ensure financial accountability and market access.
